Eli Lilly wins court ruling allowing weight-loss drug ads against Novo Nordisk
A US court denied Novo Nordisk's request to temporarily block Eli Lilly from using advertisements claiming its obesity drugs are more powerful, a setback for Novo as it battles to regain market share.
